Speaker Interview with Deciduous Therapeutics
Don't miss Deciduous Therapeutics' session on the 7th IPF Summit agenda:
Resolving Pulmonary Fibrosis via Immune Mediated Senolysis
Robin Mansukhani, Chief Executive Officer, Deciduous Therapeutics
Want to learn more about the 7th IPF Summit?